2021
DOI: 10.1016/j.jprot.2021.104152
|View full text |Cite
|
Sign up to set email alerts
|

Optimised data-independent acquisition strategy recaptures the classification of early-stage hepatocellular carcinoma based on data-dependent acquisition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 38 publications
0
6
0
Order By: Relevance
“…For all strategies, PBMCs were lysed and subjected to the optimized DIA analysis on a Q-Exactive HF mass spectrometer (Figure 1). 16 Optimization of Proteomic Workflows for Microscale PBMCs. The enriched cells were analyzed by FACS to observe the components and purity.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…For all strategies, PBMCs were lysed and subjected to the optimized DIA analysis on a Q-Exactive HF mass spectrometer (Figure 1). 16 Optimization of Proteomic Workflows for Microscale PBMCs. The enriched cells were analyzed by FACS to observe the components and purity.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Liquid chromatography-coupled tandem mass spectrometry (LC−MS/MS) is a powerful technique for proteomic studies, allowing accurate quantification of proteins from complex biological samples for further analysis. 48 An acquisition strategy plays a very important role in the analysis of LC-MS. 49 Currently, the commonly used acquisition strategy is DDA, which selects ions for analysis according to the abundance of parent ion fragments. 50 Therefore, this acquisition strategy has a certain bias, and the obtained proteomic results usually need to be further validated.…”
Section: ■ Discussionmentioning
confidence: 99%
“…The liquid chromatography-tandem mass spectrometry (LC—MS/MS) detection system consisted of a nanoflow high-performance liquid chromatography (HPLC) instrument (Easy nLC1200, Thermo Fisher) coupled to an Orbitrap Q-Exactive HF mass spectrometer (Thermo Fisher). For acquisition of mass spectra, the optimal data-independent acquisition (DIA) parameters described in the article by Shuang Weng et al [18] were used. In brief, 2 µg of the peptide mixture resolved with buffer A was loaded on a 30-cm self-packing column (150-μm inner diameter, ReproSil-Pur C18-AQ, 1.9 µm; Dr. Maisch) with a 120-min LC gradient time ( Table S2 ) at a flow rate of 600 nl/min.…”
Section: Methodsmentioning
confidence: 99%